The Latest Updates in Duchenne Muscular Dystrophy

This video is available for 0.50 AMA PRA Category 1 Credit(s)™
Click here to claim credit:

The following faculty report that they have relevant financial relationships to disclose:
Dr. Hoda Abdel-Hamid serves on the advisory board for Audentes, AveXis, and Sarepta.

Dr. Perry Shieh consults for Alexion, AveXis, Biogen, Genentech, and Sarepta. He also serves on the speakers bureau for Alexion, AveXis, Biogen, CSL Behring, Genentech and Grifols.

Dr. Aravindhan Veerapandiyan has no relevant financial relationships to disclose

Drs. Hoda Abdel-Hamid, Perry Shieh and Aravindhan Veerapandiyan share updates and data from a recent neuromuscular meeting. Hear their perspective on the clinical implications of what's new in Duchenne and Limb Girdle Muscular Dystrophies with links to abstracts and relevant data.

TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

This information is intended for health care providers.

This activity is supported by an educational grant from Sarepta Therapeutics, Inc.

Link to full activity: